Clumping the data to include all thrombolytics is not helpful, as only alteplase (tPA) is clinically used. We have moved on from the old thrombolytics.
When studying the new thrombolytic Tenecteplase in a RCT, we will not compare it to streptokinase. Thats not helpful.